The predictive ability of blood pressure in elderly trial patients

Journal of Hypertension

Volumn 30, Issue 9, 2012, Pages 1725-1733

  Carr, Matthew J ^a   Bao, Yanchun ^b   Pan, Jianxin ^a   Cruickshank, Kennedy ^c   McNamee, Roseanne ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b BRUNEL UNIVERSITY   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

blood pressure; cardiovascular disease; longitudinal data; matched case control analysis; risk factors

Indexed keywords

AMILORIDE; ATENOLOL; HYDROCHLOROTHIAZIDE; PLACEBO;

AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; GERIATRIC PATIENT; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); STROKE; SYSTOLIC BLOOD PRESSURE;

EID: 84865455988     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3283568a73     Document Type: Article

References (37)

1. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual BP to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360:1903-1913. (Pubitemid 35472129)
2. Rothwell PM,Howard SC,Dolan E, O'Brien E,Dobson JE,DahlÖ fB, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010; 375:895-905.
3. Webb AJS, Fischer U, Mehta Z, Rothwell PM. Effects of antihypertensivedrug class on inter-individual variation in blood pressure and risk of stroke: a systematic reviewand meta-analysis. Lancet 2010; 375:906-915.
4. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, DahlÖf B, et al. Effects of ( blockers and calcium-channel blockers on withinindividual variability in blood pressure and risk of stroke. Lancet Neurol 2010; 9:469-480.
5. Rothwell PM. Limitations of the usual blood pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet 2010; 375:938-948.
6. MRC Working Party. MRC trial of treatment of hypertension in older adults: principal results. BMJ 1992; 304: 405-412.
7. Lever AF, Brennan PJ. MRC trial of treatment in elderly hypertensives. Clin Exp Hypertens 1993; 15:941-952. (Pubitemid 23344570)
8. Frattola A, Parati G, Cuspidi C, Albini F, Mancia G. Prognostic value of 24-h blood pressure variability. J Hypertens 1993; 11:1133-1137. (Pubitemid 23307888)
9. Parati G, Valentini M. Prognostic relevance of blood pressure variability. Hypertension 2006; 47:137-138. (Pubitemid 43189750)
10. Parati G. Blood pressure variability: its measurement and significance in hypertension. J Hypertens 2005; 23:S19-S25.
11. Kikuya M, Hozawa A, Ohokubo T, Tsuji I, Michimata M, Matsubara M, et al. Prognostic significance of blood pressure and heart rate variabilities: the Ohasama study. Hypertension 2000; 38:23-29.
12. Pringle E,Phillips C,Thijs L,Davidson C, Staessen JA, de LeeuwPW, et al., on behalf of the Syst-Eur investigators. Systolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive population. J Hypertens 2003; 21:2251-2257. (Pubitemid 38293563)
13. Materson BJ. Variability in response to antihypertensive drugs. Am J Med 2007; 120 (4A):S10-S20. (Pubitemid 46497039)
14. Mancia G, Parati G, Di Rienzo M, Zanchetti A. Blood pressure variability. In: Zanchetti A, Mancia G, editors. Handbook of hypertension. Amsterdam: The Netherlands: Elsevier; 1997. pp. 117-169.
15. Kario K, Pickering TG,Umeda Y,Hoshide S,Hoshide Y,Morinari M, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation 2003; 107:1401-1406. (Pubitemid 36350739)
16. Grove JS, Reed DM, Yano K, Hwang L (Pubitemid 27188513)
17. Mancia G, Messerli F, Bakris G, Zhou Q, Champion A, Pepine CJ. Blood pressure control and improved cardiovascular outcomes in the international Verapamil SR-Trandolapril Study. Hypertension 2007; 50:299-305. (Pubitemid 47205777)
18. Menotti A, Lanti M, Kafatos A, Nissinen A, Dontas A, Nedeljkovic S, Kromhout D. The role of a baseline casual blood pressure measurement and of blood pressure changes in middle age in prediction of cardiovascular and all-cause mortality occurring late in life: a crosscultural comparison among the European cohorts of the Seven Countries Study. J Hypertens 2004; 22:1683-1690. (Pubitemid 39141959)
19. Boshuizen HC, Lanti M, Menotti A, Moschandreas J, Tolonen H, Nissinen A, et al. Effects of past and recent blood pressure and cholesterol level on coronary heart disease and stroke mortality, accounting for measurement error. Am J Epidemiol 2007; 165:398-409.
20. Du X, Cruickshank JK, McNamee R, Saraee M, Sourbutts J, Summers A, et al. Case-control study of stroke and the quality of hypertension control in north-west England. BMJ 1997; 314:272-276. (Pubitemid 27047383)
21. Convanico V, De Caprio L, Vigorito C, Forgione L, Tedeschi C, Guarini P, Rengo F. Differences in blood pressure profile between young and elderly hypertensive patients. J Human Hypertens 1990; 4:405-409. (Pubitemid 20260459)
22. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010; 55:1318-1327.
23. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, et al. Blood pressure, stroke, and coronary heart disease. Part 2, Shortterm reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335:827-838. (Pubitemid 20113741)
24. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335:765-774. (Pubitemid 20106689)
25. Stergiou GS, Zourbaki AS, Skeva II, Mountokalakis TD. White coat effect detected using self-monitoring of blood pressure at home: comparison with ambulatory blood pressure. Am J Hypertens 1998; 11:820-827. (Pubitemid 28351015)
26. Pickering TG, James GD, Boddie C, Harshfield GA, Blank S, Laragh JH. How common is white coat hypertension? JAMA 1988; 259:225-228. (Pubitemid 18026263)
27. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics 1982; 38:963-974.
28. Tsiatis AA, DeGruttola V, Wulfsohn MS. Modeling the relationship of survival to longitudinal data measured with error. Applications to Survival and CD4 Counts in Patients with AIDS. J Am Stat Assoc 1995; 90:27-37.
29. Clarke R, Shipley M, Lewington S, Youngman L, Collins R, Marmot M, Peto R. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol 1999; 150:341-353. (Pubitemid 29383482)
30. Breslow NE, Lubin JH, Marek P, Langholtz B. Multiplicative models and the analysis of cohort data. J Am Stat Assoc 1983; 78:1-12.
31. Prentice RL, Breslow NE. Retrospective studies and failure time models. Biometrika 1978; 65:153-158. (Pubitemid 8308397)
32. Harrell FE. Regression modelling strategies, 1st ed. New York: Springer; 2001. pp. 53-84.
33. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009; 338:b1665.
34. Boutitie F, Gueyffier F, Pocock SJ, Boissel JP. Assessing treatment-time interaction in clinical trials with time to event data: a meta-analysis of hypertension trials. Stat Med 1998; 17:2883-2903. (Pubitemid 28562982)
35. Pastor-Barriuso R, Banegas JR, Damian J, Appel LJ, Guallar E. Systolic blood pressure, diastolic blood pressure, and pulse pressure: an evaluation of their joint effect on mortality. Ann Intern Med 2003; 139:731-739.
36. Stergiou GS, Baibas NM, Gantzarou AP, Skeva II, Kalkana CB, Roussias LG, Mountokalakis TD. Reproducibility of home, ambulatory and clinic blood pressure: Implications for the design of trials for the assessment of antihypertensive drug efficacy. Am J Hypertens 2002; 15:101-104. (Pubitemid 34161082)
37. Williams B, Lindholm LH, Sever P. Systolic pressure is all that matters. Lancet 2008; 371:2219-2221.